WHO ICTRP trial
Camrelizumab combined with drug-loaded microsphere BACE in the treatment of…
ChiCTR2500107108 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR2500107108 |
|---|---|
| Public title | Camrelizumab combined with drug-loaded microsphere BACE in the treatment of locally advanced NSCLC:A prospective, single-arm clinical study |
| Scientific title | Camrelizumab combined with drug-loaded microsphere BACE in the treatment of locally advanced NSCLC:A prospective, single-arm clinical study |
| Primary sponsor | Zhoukou Central Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional study |
| Phase | 0 |
| Countries | China |
| Conditions | Non-small cell carcinoma |
| Interventions | Intervention group:DEB-BACE treatment (the drug loaded on the drug-loaded microsphere was carboplatin, with an AUC of carboplatin =5, one-third of which was used for the drug-loaded microsphere (Jiangsu Hengrui), and one-third was… |
| Registration date | Aug 4, 2025 |
| Target size | Intervention group:20 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: